TSE:SLF

Sun Life Financial Inc (SLF.TO)

112.09
+0.80 (0.72%)
as of Sep 4, 2026, 8:00:00 pm Market Open.
719 watching
0
Investor Insights
star iconSep 6, 2026, 12:00 am

This summary was created by AI, based on 9 opinions in the last 12 months.

Sun Life Financial Inc. (SLF) has garnered mixed reviews from experts, reflecting a blend of cautious optimism and concerns about its business model transformation. Originally focused on Canadian lifecos, the company has shifted towards mutual fund management, attracting criticism for taking on increased market beta. While some analysts acknowledge positive aspects, such as the potential benefits from rising interest rates and a robust money management division, others express concerns regarding recent challenges in asset management and the entry into private credit markets. Fundamentally, SLF trades at a comparatively lower P/E ratio than Canadian banks, but experts note that the growth rate remains modest. Overall, while the stock has rallied recently, many experts advocate for a cautious approach towards new investments, balancing potential growth against broader economic risks.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
MFC
COMMENT
They've done well in recent years by being conservative and taking little risk in some of their businesses. That's resulted in good dividends and earnings that aren't as volatile as their peers. However, their growth isn't as strong. Asian has been a bright spot for them. Overall, it's a decent company and it's safe in a volatile market, but this isn't the highest growth stock around.
COMMENT
Is China hurting MFC-T? He owned MFC-T going into the 2008 crisis. But when the management announced they had taken on undue risk, he exited. They have never really reemerged from this. They were too exposed to equity markets back then, and decided to exit equities just as the market rallied to all time highs. He thinks there are better opportunities out there -- like SLF-T.
PAST TOP PICK
(A Top Pick Dec 15/18, Down 5%) They are expanding insurance operations in Asia. They have excess capital of $2.3 billion. They could do an acquisition or buy back shares. Extremely well run so he continues to like it and hold it.
COMMENT
Had been best performing Canadian lifeco. But it's fallen out of bed, nothing is sacred in this market. Support around $40, and it's close now. Will probably bounce back, but needs to firmly break past trend line before he can call it an uptrend again.
BUY
A trend around $56 earlier this year. The other level is the current $45 range. The market is stepping in now for all lifecos. SLF just had a sudden move bouncing up from $43 as buyers come in. The $45 level is solid.
PAST TOP PICK
(A Top Pick Dec 06/17, Down 11%) It's declined with the market. Interest rates went up then down which hurt them.
COMMENT
The lifecos are attractive after this correction. Solid businesses. SLF has a big U.S. asset management operation. But she prefers (and owns) MFC which has a better valuation. In the past. SLF's earnings have outgrown MFC's, but MFC's should outpace SLF's going forward. MFC trades at a discount to SLF.
BUY
SLF-T vs. MET-N. He prefers Sunlife (SLF-T). It is higher quality and more defensive. Also they are down with the sector. There is more competition in the US vs. Canada.
PAST TOP PICK
(A Top Pick Oct 25/17, Down 6%) Still likes it. (Though, he prefers Manulife now with a lower multiple.) SLF is a good buy today than when he picked it. Lifecos will do well as interest rates rise.
BUY
Largest foreign insurer in India. Great global assets, conservatively managed. Earnings growing at 12-14% for next couple of years. Premier, best run Canadian insurer. Great dividend yield and growing. Compelling investment.
WEAK BUY
Reasonable dividend, though not as good as the banks. If you want a financial outside of the banks, this would be his choice in the space. Yield is just over 4%.
HOLD
They are still guiding for 8-10% earnings growth. They are stable. They should be able to grow the dividend 4-5% a year. It is off along with the market. This and MFC-T are global companies now. MFC-T looks cheaper so he would buy that over SLF-T, which is trading at a 10% premium to its market multiple. Don't sell it.
COMMENT
Q3 beat--earnings were way up. Double-digit growth in the US. Asia operations were a lower weak. 4% EPS growth only. Pricey vs. peers. Manulife has a better growth rate, and he prefers MFC. The lawsuit they face--MFC will be okay.
PARTIAL BUY
It has followed the trends of the financial sector to some degree. It looks solid where it is right now. It is making money. It is probably better value than it was in the summer. Take a small position, or the XFN-T ETF to diversify, preferably. If it drops below $47 there is not much support below that. There is resistance at $51.
COMMENT

It is a pretty safe company with a reasonable dividend. He would not buy it until there is a blow off. Insider selling has been very heavy. It is a leader in the Canadian field. If you want to put it away, it is a good one for that purpose.

Showing 136 to 150 of 1,051 entries